ReviewCancer cell international2026
Deciphering the cancer chemopreventive potential of phytochemicals: an integrative perspective on molecular targets and signaling networks.
Review in Cancer cell international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Natural Products in Prostate Cancer: Crosstalk Among the Gut Microbiome, Androgen Receptor Signaling, and Epigenetic Regulation.International journal of molecular sciences · 2026Review
- Dietary Phytochemicals in Cancer Therapy-From Mechanistic Insights to Combination Strategies.Nutrients · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cell death, cell proliferation, cell differentiation, cell invasion and cell migration are the fundamental cellular processes which are dysregulated due to the perturbed cell signaling pathways leading to cancer. These biological pathways leading to cancer are intertwined. Genes controlling these pathways are mutated due to the various cellular insults and hence result in cancer stem cells that proliferate without the normal regulatory molecular switches seen in noncancerous cells. The important cellular signaling pathways which are known to malfunction in cancer cells include NF–κB, Akt, MAPK, Wnt, Notch, p53, EGFR, etc. among many others. Bio-active molecules that can regulate signal transduction pathways in cancerous cells have recently emerged as a popular research area in biomedicine. Bio-molecules or phytochemicals modulate the signaling pathways and are widely appreciated as anti-cancer agents synergizing with the chemotherapy. Wnt signaling has been implicated in the tumorigenesis and is an attractive therapeutic target. Similarly, polyphenols are known to have an effect on the caspase cascade and are known to play a modulatory role in the process of apoptosis by interfering with the PI3K/Akt cell signaling pathway. EGFR is elevated in tumorigenesis, and phytochemicals are known to have downregulating effects by inhibiting the protein tyrosine activities of PTK of EGFR. Nuclear factor- kB has been well documented to be aberrant in the cell signaling pathway and is looked at as an important therapeutic target. Therefore, many investigators have focused on finding the molecular targets of these natural phyto-compounds. Since aberrant cell signaling plays a central role in cancer progression, the subject of the review is the activity of phytochemicals as bioactive regulators of the pathways, i.e., Wnt, NF-kB, and PI3K/Akt, with insights provided into the mechanism by which they can be used as complementary anti-cancer agents.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.